Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase
Observational
Started
2025-04-01
Last updated
2025-08-27
Condition(s) studied
PretermSmall Gestational Age (SGA)
Study summary
The goal of this nationwide multicenter observational study is to comprehensively investigate the severity of Small Vulnerable Newborns (SVN) issues across China and to propose further preventive and intervention measures. The primary aim is to provide a thorough description of SVN problems using a unified definition and framework, and to develop targeted prevention strategies.
Participating centers across the country will collect clinical data on vulnerable newborns under their care and complete detailed questionnaires to support this research.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Newborns diagnosed as vulnerable infants at the participating hospitals between January 1 and December 31, 2024;
2. Meeting any one of the following criteria:
* Diagnosed as small for gestational age (SGA): birth weight below the 10th percentile for infants of the same gestational age and sex;
* Preterm infants: gestational age less than 37 weeks;
* Low Birth Weight (LBW) infants: birth weight less than 2,500 grams.
Exclusion Criteria:
* Incomplete medical records due to missing data preventing comprehensive case evaluation.
Primary outcome measure(s)
Number of small vulnerable newborns — From date of hospital admission until the date of discharge or date of death from any cause, whichever came first, assessed up to 1 year.
Mortality rate — From date of hospital admission until the date of discharge or date of death from any cause, whichever came first, assessed up to 1 year.
Trial sites (1)
Facility
City
Region
Status
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai
Shanghai Municipality
Recruiting
More Xinhua Hospital, Shanghai Jiao Tong University School of Medicine trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.